Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This is a study that will follow transplant patients from Study A3921030 to monitor for long
term safety, tolerability and efficacy for 5 additional years, except in Portugal where the
study will follow transplant patients through Month 36 posttransplant. Patients will continue
their study medications that were previously assigned.